Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro

Effects of HMG CoA reductase inhibitor on cholesterol absorption in obesity: Implications for the regulation of very-low-density lipoprotein B-100 metabolism

Atherosclerosis Supplements ◽

10.1016/s1567-5688(02)80779-6 ◽

2002 ◽

Vol 3 (2) ◽

pp. 235

Keyword(s):

Reductase Inhibitor ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Cholesterol Absorption ◽

Very Low Density Lipoprotein ◽

Low Density ◽

Hmg Coa Reductase ◽

HMG-CoA reductase inhibitor decreases small dense low-density lipoprotein and remnant-like particle cholesterol in patients with type-2 diabetes

Life Sciences ◽

10.1016/s0024-3205(02)02038-6 ◽

2002 ◽

Vol 71 (20) ◽

pp. 2403-2412 ◽

Cited By ~ 31

Author(s):

Hirohito Sone ◽

Akimitsu Takahashi ◽

Hitoshi Shimano ◽

Shun Ishibashi ◽

Gen Yoshino ◽

...

Keyword(s):

Type 2 Diabetes ◽

Reductase Inhibitor ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Hmg Coa Reductase ◽

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

Atherosclerosis ◽

10.1016/0021-9150(91)90017-w ◽

1991 ◽

Vol 87 (2-3) ◽

pp. 147-157 ◽

Cited By ~ 40

Author(s):

Jiana Yuan ◽

Michael Y. Tsai ◽

Janet Hegland ◽

Donald B. Hunninghake

Keyword(s):

Reductase Inhibitor ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Hmg Coa Reductase ◽

The Relationship Between Apolipoprotein B-100 and Low-Density Lipoprotein Cholesterol after Treatment with an HMG CoA Reductase Inhibitor

American Journal of Clinical Pathology ◽

10.1093/ajcp/92.4.479 ◽

1989 ◽

Vol 92 (4) ◽

pp. 479-483 ◽

Cited By ~ 3

Author(s):

Stanley S. Levinson ◽

Roger D. Blevins ◽

Michael P. Smith ◽

Melvin Rubinfire ◽

James J. Maciejko

Keyword(s):

Apolipoprotein B ◽

Reductase Inhibitor ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Coa Reductase ◽

The Relationship

SYNERGISTIC REDUCTION IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL WITH COMBINED HMG-COA REDUCTASE INHIBITOR AND AEROBIC EXERCISE THERAPY IN OBESE, HYPERCHOLESTEROLEMIC MALES

Medicine & Science in Sports & Exercise ◽

10.1097/00005768-200205001-00273 ◽

2002 ◽

Vol 34 (5) ◽

pp. S50

Author(s):

K P. Honeal ◽

I W. Waters ◽

J S. Hallam ◽

J Fullenwider ◽

C McIntosh ◽

...

Keyword(s):

Aerobic Exercise ◽

Exercise Therapy ◽

Reductase Inhibitor ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Low Density Lipoprotein Cholesterol ◽

Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy

Atherosclerosis ◽

10.1016/0021-9150(94)05439-p ◽

1995 ◽

Vol 113 (2) ◽

pp. 157-166 ◽

Cited By ~ 125

Author(s):

Jose M. Ordovas ◽

Jose Lopez-Miranda ◽

Francisco Perez-Jimenez ◽

Carmen Rodriguez ◽

Jong-Soon Park ◽

...

Keyword(s):

Apolipoprotein E ◽

Reductase Inhibitor ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Inhibitor Therapy ◽

Low Density ◽

Hmg Coa Reductase ◽

Lipoprotein Response ◽

Lipoprotein Receptor Related Protein

Up-regulation of hepatic low-density lipoprotein receptor–related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl–coenzyme A reductase inhibitor

Metabolism ◽

10.1016/j.metabol.2010.08.013 ◽

2011 ◽

Vol 60 (7) ◽

pp. 930-940 ◽

Cited By ~ 27

Author(s):

Jae Hoon Moon ◽

Saet Byol Kang ◽

Jong Suk Park ◽

Byung Wan Lee ◽

Eun Seok Kang ◽

...

Keyword(s):

Reductase Inhibitor ◽

Coenzyme A ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Lipoprotein Receptor ◽

Related Protein ◽

Low Density Lipoprotein Receptor ◽

Density Lipoprotein Receptor ◽

Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia

Journal of Clinical Laboratory Analysis ◽

10.1002/(sici)1098-2825(2000)14:3<125::aid-jcla7>3.0.co;2-s ◽

2000 ◽

Vol 14 (3) ◽

pp. 125-131 ◽

Cited By ~ 26

Author(s):

Luis A. Salazar ◽

Mario H. Hirata ◽

�der C.R. Quint�o ◽

Rosario D.C. Hirata

Keyword(s):

Reductase Inhibitor ◽

Receptor Gene ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Lipid Lowering ◽

Lipoprotein Receptor ◽

Primary Hypercholesterolemia ◽

Density Lipoprotein Receptor ◽

Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL) -apheresis

Atherosclerosis ◽

10.1016/0021-9150(88)90079-2 ◽

1988 ◽

Vol 72 (2-3) ◽

pp. 183-188 ◽

Cited By ~ 15

Author(s):

Hiroshi Mabuchi ◽

Hajime Fujita ◽

Ichiro Michishita ◽

Mitsuaki Takeda ◽

Kouji Kajinami ◽

...

Keyword(s):

Serum Lipid ◽

Coenzyme A ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Ldl Apheresis ◽

Hmg Coa Reductase ◽

Inhibitory effects of rosa roxburghii tratt juice on in vitro oxidative modification of low density lipoprotein and on the macrophage growth and cellular cholesteryl ester accumulation induced by oxidized low density lipoprotein

Clinica Chimica Acta ◽

10.1016/s0009-8981(01)00647-7 ◽

2001 ◽

Vol 313 (1-2) ◽

pp. 37-43 ◽

Cited By ~ 19

Author(s):

Chunni Zhang ◽

Xiaozhuan Liu ◽

Hongjuan Qiang ◽

Ke Li ◽

Junjun Wang ◽

...

Keyword(s):

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Oxidative Modification ◽

Low Density ◽

Oxidized Low Density Lipoprotein ◽

Inhibitory Effects ◽

Rosa Roxburghii Tratt ◽

Rosa Roxburghii ◽

Cholesteryl Ester Accumulation